Publication | Closed Access

Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis

Myelin ProteinsAutoimmune DiseaseAutoantibody ProductionClinical DeficitsImmunodeficienciesMedicineImmunologyAutoimmunityAutoantibodiesBrain-immune InteractionNeurologyLesion SeverityImmunologic DiseaseNeuropathologyNeuroimmunology